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High alcohol consumption is related to colorectal cancer (CRC). Our objective was to study associations between alcohol consumption and risk of
CRC according to characteristics of aetiological pathways: the chromosomal instability (CIN) and the microsatellite instability (MIN) pathway.
We classified CINþ tumours (tumours with either a truncating APC mutation, an activating K-ras mutation or overexpression of p53), MINþ
tumours (tumours lacking hMLH1 expression) and CIN2/MIN2 tumours (tumours without these defects). In the Netherlands Cohort Study on
diet and cancer, 120 852 men and women, aged 55–69 years, completed a questionnaire on risk factors for cancer at baseline (1986). Case–
cohort analyses were conducted using 573 CRC cases with complete data after 7·3 years of follow-up, excluding the first 2·3 years. Adjusted
incidence rate ratios (RR) and 95% confidence intervals (CI) were estimated. Compared with abstaining, alcohol consumption of $30 g/d was
positively associated with the risk of CRC irrespective of genetic or molecular aberrations present, although statistical significance was not reached
(RR 1·35 (95% CI 0·9–2·0) for the CINþ tumours, RR 1·59 (95% CI 0·4–5·8) for the MINþ tumours and RR 1.15 (95% CI 0·5–2·7) for the
CIN2/MIN2 tumours). Beer, wine and liquor consumption were, independent of their alcoholic content, not consistently associated with the
risk of CRC within the defined subgroups. In conclusion, our results indicate that a daily alcohol consumption of $30 g is associated with an
increase in risk of CRC, independent of the presence or absence of the studied characteristics of different aetiological pathways.
Alcohol: Colorectal cancer: Genetics: Cohort study: The Netherlands
Colorectal cancer (CRC) is characterised by multiple chromoso-
mal abnormalities. It is one of the best studied models represent-
ing the multistep nature of tumorigenesis. Sporadic CRC may
develop through at least two independent pathways, i.e. the chro-
mosomal instability (CIN) and the microsatellite instability
(MIN) pathways. The CIN pathway is characterised by aneu-
ploidy/polyploidy and mutations in APC, K-ras, p53 and DCC
genes, and occasionally in SMAD2 and SMAD4 genes. The
MIN pathway, on the other hand, is characterised by alterations
in small stretches of short repetitiveDNAsequences (microsatel-
lites), and deficiency in DNA mismatch repair (MMR) which is
often caused by promoter methylation of the MMR gene
hMLH1 (Rashid et al. 1999; Arnold et al. 2004). Colorectal car-
cinomas that evolve through the CIN or MIN pathways differ in
several pathological features such as tumour sublocalisation,
tumour differentiation and patient survival (Salahshor et al.
1999; Samowitz et al. 2001; Giaretti et al. 2004; Lu¨chtenborg
et al. 2005). This indicates that various environmental risk fac-
tors, such as dietary habits and lifestyle factors,may play a differ-
ent role in the aetiology of CIN and MIN colorectal tumours.
The association between alcohol consumption and CRC has
long been debated. Although alcohol itself is not carcinogenic,
alcohol’s first metabolite, acetaldehyde, is emerging as an
important malefactor, being able to form stable DNA adducts,
trigger mutations in tumour suppressors and oncogenes, and
interfere with DNA repair (Poschl et al. 2004).
Several epidemiological studies have investigated associ-
ations between alcohol consumption and single genetic
events involved in CRC, such as mutations in APC and
K-ras genes, MIN and overexpression of p53 (Fredrikson
et al. 1996; Slattery et al. 2000; Voskuil et al. 2000; Samo-
witz et al. 2001; Diergaarde et al. 2003a,b; Terry et al.
2003). Although these studies focused merely on a single
gene and their results are not consistent, all positive associ-
ations that were found linked alcohol consumption to colo-
rectal carcinomas harbouring the mutated version of the
studied gene, but not the wild-type version. What needs
further elucidation are the aetiological pathway(s) by
which alcohol consumption may contribute to colorectal
tumorigenesis.
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Our aim was to study the associations between alcohol
consumption and the risk of CRC in subgroups of tumours,
according to their genetic and molecular aberrations. We
defined CINþ tumours as colorectal tumours with either a
truncating APC mutation, an activating K-ras mutation or
overexpression of p53, since these genes can be considered
as key genes of the CIN pathway. MINþ tumours were defined
according to a key feature of the MIN pathway, i.e. lack of
hMLH1 expression. A third group of colorectal tumours was
identified as CIN2/MIN2, i.e. tumours without the genetic
and molecular aberrations characteristic for the CINþ and
MINþ tumours.
The current study was conducted within the ongoing
Netherlands Cohort Study on diet and cancer, and is the first
to study alcohol consumption and subgroups of colorectal
tumours, based on independent aetiological pathways of disease.
Materials and methods
Study population
In September 1986, the Netherlands Cohort Study on diet and
cancer was initiated (van den Brandt et al. 1990a). Briefly,
120 852 men and women, aged 55–69 years and originating
from 204 municipal population registries throughout the
country completed an extensive self-administered question-
naire on daily dietary habits, lifestyle and other risk factors
for cancer. Newly diagnosed cancer cases were identified
through annual record linkage to the Netherlands Cancer
Registry and to PALGA, a nationwide database of histo-
and cytopathology reports (van den Brandt et al. 1990b).
The present analyses were carried out over a 7·3-year period
of follow-up, excluding the first 2·3 years. Hence, 925 histo-
logically confirmed CRC cases were identified between
January 1989 and January 1994, of whom 815 could be
linked to a PALGA report of the lesion.
Data processing and analysis were done according to the
case–cohort approach: cases were identified in the entire
cohort, while a random sample of the cohort (subcohort)
was used to estimate person-years at risk accumulating in
the cohort. A subcohort of 5000 men and women was fol-
lowed-up biennially to assess information on vital status and
migration. Prevalent cancer cases, other than non-melanoma
skin cancer, were excluded from the subcohort, as well as sub-
jects who were deceased or were diagnosed with cancer during
the first 2·3 years of follow-up. This left 4673 subcohort mem-
bers for analyses.
Assessment of exposure
Information on alcohol consumption was obtained from the
baseline questionnaire, which comprised a 150-item semi-
quantitative FFQ. This questionnaire has been validated
against a 9 d diet record (Goldbohm et al. 1994). The Spear-
man correlation coefficient between mean daily alcohol con-
sumption assessed by the questionnaire and estimated from
the 9 d diet record was 0·89 for all subjects and 0·85 for
users of alcoholic beverages. The absolute amount of alcohol
consumption reported in the questionnaire by users of alco-
holic beverages was, on average, 86% of that reported in
the 9 d diet record.
Tissue samples and molecular analyses
Of the 815 eligible CRC cases, 771 formalin-fixed, paraffin-
embedded tissue blocks could be retrieved from Dutch pathol-
ogy archives. Samples that did not contain carcinoma tissue
were excluded. As previously described, tissue samples of
734 CRC cases were available for molecular analyses of
K-ras (Brink et al. 2003) and APC (Lu¨chtenborg et al.
2004) genes, and immunohistochemical staining of hMLH1
(Lu¨chtenborg et al. 2005) and p53.
Immunohistochemical staining for p53 was performed on
archival adenocarcinoma specimens of all 734 CRC cases
according to the avidin–biotin–peroxidase complex method,
using the DO-7 mouse monoclonal antibody (DAKO A/S,
Denmark). Immunostained slides and negative controls were
evaluated semi-quantitatively and independently by two obser-
vers without knowledge of clinical parameters. We defined
cases positive for overexpression of p53 if 20% or more of
the tumour cell nuclei showed positive staining with the
antibody.
Statistical analysis
All subjects with complete information on alcohol consump-
tion and confounding variables derived from the baseline
questionnaire, and CRC cases for whom information on
APC, K-ras, p53 and hMLH1 status was also known, were
included in the statistical analysis (4076 subcohort members
and 573 CRC cases).
Incidence risk ratios (RR) and corresponding 95% confi-
dence intervals (CI) were estimated using Cox proportional
hazards models. Total alcohol consumption was divided into
three categories: 0, ,30·0 and $30·0 g/d, in line with the
results of a recent pooled analysis that suggested a threshold
in alcohol consumption above which the risk of CRC increases
(Cho et al. 2004). Consumption of beer, wine and liquor were
considered dichotomously. Analyses were adjusted for age at
baseline (years), sex, BMI (kg/m2), family history of CRC
(yes v. no), daily intakes of total energy (kJ/d), linoleic acid
(g/d) and calcium (mg/d), and smoking (never, ex, current
smoker). The analyses of the alcoholic beverages were
additionally adjusted for total alcohol intake (categorised as
0, ,30·0 and $30·0 g/d), to evaluate the role of the specific
beverage independently of its alcoholic content. The analyses
were performed using the STATA statistical software package
(version 9.1).
Results
Table 1 shows drinking habits and baseline characteristics of
the subcohort and CRC cases classified according to the stud-
ied genetic and molecular defects. Of the 471 CINþ colorectal
tumours, 38 (8%) tumours only had a truncating APC
mutation, 46 (9%) only had an activating K-ras mutation
and 168 (36%) tumours only showed overexpression of p53.
In addition, 174 (37%) of the CINþ tumours had two of the
described aberrations and 45 (10%) had all three aberrations.
Compared with the CINþ cases, the MINþ cases comprised
significantly more female cases, had fewer liquor consumers
and a lower daily intake of total energy. No differences in
drinking habits or baseline characteristics between the
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CIN2/MIN2 cases and both CINþ and MINþ cases were
observed.
Table 2 reports the RR and 95% CI for total alcohol con-
sumption and different types of alcoholic beverages, and the
risk of CRC according to the presence or absence of specific
genetic and molecular aberrations. Compared with abstaining,
consumption levels of total alcohol $30 g/d were associated
with an increased risk of CRC irrespective of genetic or mol-
ecular aberrations present, although statistical significance was
not reached (RR: 1·35 (95% CI: 0·9–2·0) for the CINþ
tumours, RR: 1·59 (95% CI: 0·4–5·8) for the MINþ tumours
and RR: 1·15 (95% CI: 0·5–2·7) for the CIN2/MIN2
tumours). Beer, wine and liquor consumption, after adjustment
for total alcohol intake, showed no clear relationship with
CINþ, MINþ and CIN2/MIN2 tumours.
Discussion
We investigated associations between alcohol consumption
and the risk of CRC by involvement of the CIN and MIN
aetiological pathways in a large prospective study. In this
study, we defined CINþ tumours as tumours harbouring
either a truncating APC mutation, an activating K-ras
mutation or overexpression of p53, and the MINþ tumours
as tumours lacking expression of hMLH1. A third group of
colorectal tumours did not harbour any of these defects and
was defined as CIN2/MIN2. Our results indicate that,
compared with abstaining, alcohol consumption levels
$30 g/d were associated with an increased risk of CRC,
which was observed in all three subgroups, although statistical
significance was not reached. Within all three subgroups, no
associations were observed between different alcoholic bev-
erages adjusted for total alcohol consumption, and the risk
of CRC.
In line with the present results, positive associations
between alcohol consumption and CRC with single genetic
or molecular aberrations have been reported for colorectal
tumours that showed overexpression of p53 and colon tumours
with MIN (Fredrikson et al. 1996; Samowitz et al. 2001;
Diergaarde et al. 2003a; Terry et al. 2003), but not for
colon tumours harbouring mutations in the APC and K-ras
genes (Slattery et al. 2000; Diergaarde et al. 2003b). We per-
formed additional analyses for alcohol consumption and the
risk of CRC in which we considered each genetic or molecular
aberration independently of any other simultaneously present
genetic or molecular aberration(s), but the results of these
analyses did not alter our present conclusions.
The pathological effects of alcohol consumption on the colo-
rectal tract have been extensively investigated but still remain
largely unclear. Evidence exists for the involvement of acet-
aldehyde (Taylor & Rehm, 2005), but also other mechanisms
have been linked to CRC, e.g. the induction of reactive oxygen
species through the induction of cytochrome P-450 2E
(Badger et al. 2003; Seitz et al. 2005; Boffetta & Hashibe,
Table 1. Drinking habits and baseline characteristics (mean and SD) of the subcohort members and subgroups of CRC characterized by specific
genetic and molecular aberrations, the Netherlands Cohort Study (1986–1993)
(Mean values and standard deviations)
Subcohort CINþ tumours* MINþ tumours† CIN2/MIN2 tumours‡
Mean SD Mean SD Mean SD Mean SD
n 4076 471 32 87
Age (years) 61·3 4·2 62·6 41 63·5 4·4 63·4 3·7
Sex (% male) 50 59 41 52
Alcohol consumption
Total alcohol (g/d) 10·4 14·4 11·8 15·3 10·9 14·8 10·8 13·0
Beer (glasses/week) 1·7 5·3 1·8 4·7 2·0 7·3 1·8 5·9
Wine (glasses/week 2·6 5·0 2·8 5·5 3·9 7·4 2·5 4·8
Liquor (glasses/week) 2·5 5·2 3·0 5·6 1·5 3·4 2·9 5·7
Molecular characteristics§
Truncating APC mutation 201 0 0
Activating K-ras mutation 194 0 0
Overexpression of p53 340 0 0
Lack of hMLH1 expression 0 32 0
Other lifestyle factors
Family history of CRC (% yes) 6 10 13 15
BMI (kg/m2) 25·0 3·1 25·5 3·0 25·5 3·4 25·4 3·7
Energy intake (kJ/d) 8074 2160 8162 2060 7294 1713 7990 2041
Linoleic acid intake (g/d){ 14·4 7·5 15·1 7·7 14·2 5·7 14·8 8·1
Calcium intake (mg/d)k 925 282 932 270 888 219 934 271
Smoking (%)
Never smoker 36 32 28 33
Ex-smoker 36 46 41 50
Current smoker 28 22 31 17
CRC, colorectal cancer; CIN, chromosome instability; MIN, microsatellite instability.
*Defined as colorectal tumours presenting either a truncating APC mutation, an activating K-ras mutation or overexpression of p53.
†Defined as colorectal tumours presenting lack of hMLH1 expression only.
‡Defined as colorectal tumours presenting no truncating APC mutation, nor an activating K-ras mutation, overexpression of p53 or lack of hMLH1 expression.
§Of the CINþ tumours, thirty-eight harboured a truncating APC mutation only, forty-six an activating K-ras mutation only and 168 only showed overexpression of p53.
In addition, 174 CINþ tumours harboured two of these aberrations and forty-five harboured all three aberrations.
{Adjusted for total energy intake.
kAdjusted for energy intake from dairy products.
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2006). Other molecular changes seen in CRC involve alterations
in DNA methylation, e.g. induction of expression of oncogenes
and silencing of tumour suppressor genes. Choi et al. (1999)
demonstrated that chronic alcohol consumption causes genomic
DNA hypomethyation in rats, whereas no effect was seen on the
methylation status of the tumour suppressor gene p53. Next to
effects at the genomic level, alcohol may also affect the colorec-
tal mucosa. As shown in experimental studies, decreasing cell
numbers in the functional compartment of the colonic crypt
through acetaldehyde, trigger compensatory hyper-regeneration
with increased crypt cell production rates and extension of the
proliferative compartment towards the lumen of the crypt
(Seitz et al. 1990; Simanowski et al. 2001). Mucosal hyper-
regeneration, regardless of the underlying cause, is strongly
associated with CRC risk. Many of the above-described pro-
cesses have been observed in heavy or chronic alcohol consu-
mers. The amount of damage related to alcohol tends to follow
a dose–response relationship and, as such, (very) high levels
of daily alcohol intake may be needed for genetic mutations to
occur. Moderate consumption levels, as in our study population,
might thus not be able to increase CRC risk through causing
specific genetic or molecular aberrations. In addition, besides
adverse effects of alcohol consumption, the entire nutritional
status in heavy drinkers may be impaired due to malnutrition
and intestinal absorption, increasing the cancer risk even more.
The strengths of our study include a population-based and
prospective design. In addition, the high completeness of
follow-up of cancer incidence and subcohort members pre-
cluded minimal recall and selection biases. Although the
CIN and MIN pathways also involve aberrations other than
the ones that were included in the current study, APC, K-ras
and p53 are key genes of the CIN pathway, as hMLH1 is a
key gene of the MIN pathway. Our study is currently the
first prospective study that investigated the association
between alcohol consumption and distinct CRC subgroups.
Nevertheless, it should be noted that the numbers of CRC
cases in certain subgroups are small and results should be
interpreted with caution.
In conclusion, our results indicate that a daily alcohol con-
sumption of $30 g is positively associated with the risk of
CRC. This increase in risk was observed independent of the
presence or absence of the genetic and molecular aberrations
we studied to distinguish between aetiological pathways.
Acknowledgements
We are indebted to the participants of this study and further
thank the regional cancer registries (IKA, IKL, IKMN, IKN,
IKO, IKR, IKST, IKW, IKZ and VIKC), and the Netherlands
nationwide registry of pathology (PALGA). We also thank all
the Dutch pathology laboratories for their cooperation in pro-
viding the tissue blocks, Dr M. Brink for the collection of
tissue samples, Dr A. de Bruı¨ne for expert pathological
advice, Dr M. Brink, Dr M. Lu¨chtenborg, P. Wark,
G. Roemen, K. Wouters and Dr M van Engeland for molecular
analyses, Dr L. Schouten, S. van de Crommert, H. Brants, J.
Nelissen, C. de Zwart, M. Moll, W. van Dijk, M. Jansen
and A. Pisters for data management, and H. van Montfort,
T. van Moergastel, L. van den Bosch and R. Schmeitz for pro-
gramming assistance. Finally, we thank Dr A. Volovics and Dr
A. Kester for statistical advice. Financial support for collec-
tion of tumour material and mutation analyses was provided
by a grant from the Dutch Cancer Society and financial sup-
port for the current study is provided by a grant from the Euro-
pean Research Advisory Board (ERAB).
References
Arnold CN, Goel A, Compton C, et al. (2004) Evaluation of micro-
satellite instability, hMLH1 expression and hMLH1 promoter
hypermethylation in defining the MSI phenotype of colorectal
cancer. Cancer Biol Ther 3, 73–78.
Table 2. Incidence rate ratios for subgroups of colorectal cancer characterized by specific genetic and molecular aberrations, according to drinking
habits, adjusted for confounders*, the Netherlands Cohort Study (1986–1993)
Person-years
in subcohort
CINþ tumours† MINþ tumours‡ CIN2/MIN2 tumours§
Drinking habits No. of cases RR 95% CI No. of cases RR 95% CI No. of cases RR 95% CI
Total alcohol (g/d)
No alcohol 6762 103 1·00 9 1·00 22 1·00
, 30·0 19 656 308 0·97 0·8, 1·2 19 0·81 0·4, 1·9 56 0·87 0·5, 1·5
$ 30·0 2624 60 1·35 0·9, 2·0 4 1·59 0·4, 5·8 9 1·15 0·5, 2·7
Beer (glasses/week){
No beer 19 320 307 1·00 25 1·00 61 1·00
Beer drinker 9722 164 0·82 0·6, 1·1 7 0·60 0·2, 1·7 26 0·85 0·5, 1·5
Wine (glasses/week){
No wine 13 601 224 1·00 16 1·00 43 1·00
Wine drinker 15 441 247 0·97 0·8, 1·2 16 0·89 0·3, 2·3 44 0·83 0·5, 1·5
Liquor (glasses/week){
No liquor 14 883 211 1·00 19 1·00 43 1·00
Liquor drinker 14 159 260 1·15 0·9, 1·5 13 0·73 0·3, 1·9 44 1·13 0·7, 1·9
CIN, chromosome instability; MIN, microsatellite instability; RR, rate ratio; CI, confidence interval.
* Adjusted for age (years), sex, BMI (kg/m2), family history of colorectal cancer (yes/no), daily energy intake (kJ/d), daily linoleic acid intake (g/d), daily calcium intake (mg/d)
and smoking (never, ex, current).
†Defined as colorectal tumours presenting either a truncating APC mutation, an activating K-ras mutation or overexpression of p53.
‡Defined as colorectal tumours presenting lack of hMLH1 expression only.
§Defined as colorectal tumours presenting no truncating APC mutation, nor an activating K-ras mutation, overexpression of p53 or lack of hMLH1 expression.
{Additionally adjusted for categories of total alcohol consumption (0, , 30·0, $30·0 g/d).
Alcohol and pathways to colorectal cancer 433
Badger TM, Ronis MJ, Seitz HK, Albano E, Ingelman-Sundberg M &
Lieber CS (2003) Alcohol metabolism: role in toxicity and carcino-
genesis. Alcohol Clin Exp Res 27, 336–347.
Boffetta P & Hashibe M (2006) Alcohol and cancer. Lancet Oncol 7,
149–156.
Brink M, de Goeij AF, Weijenberg MP, Roemen GM, Lentjes MH,
Pachen MM, Smits KM, de Bruine AP, Goldbohm RA & van
den Brandt PA (2003) K-ras oncogene mutations in sporadic color-
ectal cancer in The Netherlands Cohort Study. Carcinogenesis 24,
703–710.
Cho E, Smith-Warner SA, Ritz J, et al. (2004) Alcohol intake and
colorectal cancer: a pooled analysis of 8 cohort studies. Ann
Intern Med 140, 603–613.
Choi SW, Stickel F, Baik HW, Kim YI, Seitz HK & Mason JB (1999)
Chronic alcohol consumption induces genomic but not p53-specific
DNA hypomethylation in rat colon. J Nutr 129, 1945–1950.
Diergaarde B, Braam H, van Muijen GN, Ligtenberg MJ, Kok FJ &
Kampman E (2003a) Dietary factors and microsatellite instability
in sporadic colon carcinomas. Cancer Epidemiol Biomarkers
Prev 12, 1130–1136.
Diergaarde B, van Geloof WL, van Muijen GN, Kok FJ & Kampman
E (2003) Dietary factors and the occurrence of truncating APC
mutations in sporadic colon carcinomas: a Dutch population-
based study. Carcinogenesis 24, 283–290.
Fredrikson M, Axelson O, Sun XF, Arbman G, Nilsson E,
Nordenskjold B, Sjodahl R & Soderkvist P (1996) A pilot study
on risk factors and p53 gene expression in colorectal cancer.
Br J Cancer 73, 1428–1430.
Giaretti W, Venesio T, Prevosto C, Lombardo F, Ceccarelli J, Molinu S
&Risio M (2004) Chromosomal instability and APC gene mutations
in human sporadic colorectal adenomas. J Pathol 204, 193–199.
Goldbohm RA, van den Brandt PA, Brants HA, van’t Veer P, Al M,
Sturmans F & Hermus RJ (1994) Validation of a dietary question-
naire used in a large-scale prospective cohort study on diet and
cancer. Eur J Clin Nutr 48, 253–265.
Lu¨chtenborg M, Weijenberg MP, Roemen GMJM, de Bruı¨ne AP,
van den Brandt PA, Lentjes MHFM, Brink M, van Engeland M,
Goldbohm RA & de Goeij AFPM (2004) APC mutations in
sporadic colorectal carcinomas from The Netherlands Cohort
Study. Carcinogenesis 25, 1219–1226.
Lu¨chtenborg M, Weijenberg MP, Wark PA, Saritas AM, Roemen
GMJM, van Muijen GNP, de Bruine AP, van den Brandt PA & de
Goeij AFPM (2005) Mutations in APC, CTNNBI and K-ras genes
and expression of hMLHI in sporadic colorectal carcinomas from
the Netherlands Cohort Study. BMC Cancer 5, 160.
Poschl G, Stickel F, Wang XD & Seitz HK (2004) Alcohol and
cancer: genetic and nutritional aspects. Proc Nutr Soc 63, 65–71.
Rashid A, Zahurak M, Goodman SN & Hamilton SR (1999) Genetic
epidemiology of mutated K-ras proto-oncogene, altered suppressor
genes, and microsatellite instability in colorectal adenomas. Gut 44,
826–833.
Salahshor S, Kressner U, Pa˚hlman L, Glimelius B, Lindmark G &
Lindblom A (1999) Colorectal cancer with and without microsatel-
lite instability involves different genes. Genes Chromosomes
Cancer 26, 247–252.
Samowitz WS, Holden JA, Curtin K, et al. (2001) Inverse relationship
between microsatellite instability and K-ras and p53 gene altera-
tions in colon cancer. Am J Pathol 158, 1517–1524.
Seitz HK, Maurer B & Stickel F (2005) Alcohol consumption and
cancer of the gastrointestinal tract. Dig Dis 23, 297–303.
Seitz HK, Simanowski UA, Garzon FT, Rideout JM, Peters TJ,
Koch A, Berger MR, Einecke H & Maiwald M (1990) Possible
role of acetaldehyde in ethanol-related rectal cocarcinogenesis in
the rat. Gastroenterology 98, 406–413.
Simanowski UA, Homann N, Knuhl M, Arce L, Waldherr R,
Conradt C, Bosch FX & Seitz HK (2001) Increased rectal cell pro-
liferation following alcohol abuse. Gut 49, 418–422.
Slattery ML, Curtin K, Anderson K, Ma KN, Edwards S, Leppert M,
Potter J, Schaffer D & Samowitz WS (2000) Associations between
dietary intake and Ki-ras mutations in colon tumors: a population-
based study. Cancer Res 60, 6935–6941.
Taylor B & Rehm J (2005) Moderate alcohol consumption and dis-
eases of the gastrointestinal system: a review of pathophysiological
processes. Dig Dis 23, 177–180.
Terry MB, Neugut AI, Mansukhani M, Waye J, Harpaz N &
Hibshoosh H (2003) Tobacco, alcohol, and p53 overexpression in
early colorectal neoplasia. BMC Cancer 3, 29.
van den Brandt PA, Goldbohm RA, van’t Veer P, Volovics A,
Hermus RJ & Sturmans F (1990a) A large-scale prospective
cohort study on diet and cancer in The Netherlands. J Clin Epi-
demiol 43, 285–295.
van den Brandt PA, Schouten LJ, Goldbohm RA, Dorant E & Hunen
PM (1990b) Development of a record linkage protocol for use in
the Dutch Cancer Registry for Epidemiological Research. Int J
Epidemiol 19, 553–558.
Voskuil DW, Kampman E, Van Geloof W, Grubben M, Kok F,
Van Muijen G, Nagengast F, Vasen H & van’t Veer P (2000)
No major difference in K-ras and p53 abnormalities in sporadic
and hereditary nonpolyposis colorectal adenomas. Dig Dis Sci
45, 2187–2194.
B. W. C. Bongaerts et al.434
